Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.

Elodie HenrietAya Abou HammoudJean-William DupuyBenjamin DartiguesZakaria EzzoukryNathalie Dugot-SenantThierry Leste-LasserreNestor Pallares-LuponMacha NikolskiBrigitte Le BailJean-Frédéric BlancCharles BalabaudPaulette Bioulac-SageAnne-Aurélie RaymondFrédéric Saltel

Published in: Hepatology (Baltimore, Md.) (2017)

ASS1 + HCA combined with a typical hematoxylin and eosin stain aspect defined a new HCA subgroup at a high risk of bleeding. (Hepatology 2017;66:2016-2028).

Keyphrases

atrial fibrillation
randomized controlled trial
clinical trial
study protocol
double blind